Adamas Pharmaceuticals (ADMS) Priced

Developing improved formulations of existing drugs for CNS disorders.

Health Care - Biotechnology

IPO Performance
Latest Trade $17.21 -0.07 (-0.4%)
First Day Return -12.4%
Return from IPO 8.0%
 
Adamas Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 03/05/2014
Offer Price $16.00
Price Range $16.00 - $18.00
Offer Shares (mm) 3.0
Deal Size ($mm) 48
 
IPO Data
IPO Date 04/09/2014
Offer Price $16.00
Price Range $16.00 - $18.00
Offer Shares (mm) 3.0
Deal Size ($mm) $48
 
Underwriters
more
Business Overview
Developing improved formulations of existing drugs for CNS disorders.
Developing improved formulations of existing drugs for CNS disorders.
more
Company Data
Headquarters Emeryville, CA
Founded 2000
Employees 22
Website www.adamaspharma.com
 

Performance vs. IPO Index (IPOUSA)